Mode
Text Size
Log in / Sign up

Can Epysqli be used to treat generalized myasthenia gravis?

high confidence  ·  Last reviewed May 18, 2026

Epysqli (eculizumab-sbja) is a medication that works by blocking part of the immune system called the complement system. In generalized myasthenia gravis (gMG), the complement system can become overactive and damage the connection between nerves and muscles, leading to muscle weakness. Epysqli is specifically approved for adults with gMG who test positive for anti-acetylcholine receptor (AChR) antibodies. It is not for everyone with gMG, only for those with this specific antibody type.

What the research says

The U.S. Food and Drug Administration (FDA) has approved Epysqli for the treatment of generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor (AChR) antibody positive 1. This approval is based on evidence that complement inhibitors like Epysqli can improve symptoms and outcomes in this patient group 57. A systematic review of randomized controlled trials found that complement inhibitors (including eculizumab, the active ingredient in Epysqli) significantly improved daily living scores and muscle strength compared to placebo in AChR-positive gMG 5. The complement system plays a key role in the disease: overactivation of complement contributes to damage at the neuromuscular junction, and blocking this process with drugs like Epysqli can reduce symptoms 78. While other treatments such as IVIG and efgartigimod are also used for gMG 234, Epysqli offers a targeted option for patients with AChR antibodies who may not respond well to other therapies 8. Long-term studies of similar complement inhibitors (ravulizumab) show sustained improvements over years 6, suggesting that Epysqli may provide lasting benefit.

What to ask your doctor

  • Do I have anti-acetylcholine receptor (AChR) antibodies? This test determines if Epysqli is an option for me.
  • What are the potential side effects of Epysqli, especially the risk of meningococcal infection?
  • How does Epysqli compare with other treatments I am currently taking or considering?
  • Will I need to be vaccinated before starting Epysqli?
  • How is Epysqli administered, and how often would I need treatment?

This question is drawn from common patient questions about Hematology and answered using cited medical research. We do not provide individualized advice.